HUTCHMED (China) Ltd logo

HUTCHMED (China) Ltd - ADR

MEX:HCM (Hong Kong)   ADR
MXN 819.63 (0%) Sep 20
At Loss
P/B:
3.74
Market Cap:
MXN 140.07B ($ 7.21B)
Enterprise V:
MXN 125.77B ($ 6.48B)
Volume:
-
Avg Vol (2M):
-
Trade In:
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for HUTCHMED (China) Ltd ( ) from 2019 to Sep 21 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. HUTCHMED (China) stock (MEX:HCM) PE ratio as of Sep 21 2024 is 0. More Details

HUTCHMED (China) Ltd (MEX:HCM) PE Ratio (TTM) Chart

To

HUTCHMED (China) Ltd (MEX:HCM) PE Ratio (TTM) Historical Data

Total 971
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 11
HUTCHMED (China) PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-09-21 At Loss 2024-07-22 At Loss
2024-09-20 At Loss 2024-07-19 At Loss
2024-09-19 At Loss 2024-07-18 At Loss
2024-09-18 At Loss 2024-07-17 At Loss
2024-09-17 At Loss 2024-07-16 At Loss
2024-09-16 At Loss 2024-07-15 At Loss
2024-09-13 At Loss 2024-07-12 At Loss
2024-09-12 At Loss 2024-07-11 At Loss
2024-09-11 At Loss 2024-07-10 At Loss
2024-09-10 At Loss 2024-07-09 At Loss
2024-09-09 At Loss 2024-07-08 At Loss
2024-09-06 At Loss 2024-07-05 At Loss
2024-09-05 At Loss 2024-07-04 At Loss
2024-09-04 At Loss 2024-07-03 At Loss
2024-09-03 At Loss 2024-07-02 At Loss
2024-09-02 At Loss 2024-07-01 At Loss
2024-08-30 At Loss 2024-06-28 At Loss
2024-08-29 At Loss 2024-06-27 86.3
2024-08-28 At Loss 2024-06-26 86.3
2024-08-27 At Loss 2024-06-25 86.3
2024-08-26 At Loss 2024-06-24 86.3
2024-08-23 At Loss 2024-06-21 86.3
2024-08-22 At Loss 2024-06-20 86.3
2024-08-21 At Loss 2024-06-19 86.3
2024-08-20 At Loss 2024-06-18 86.3
2024-08-19 At Loss 2024-06-17 86.3
2024-08-16 At Loss 2024-06-14 86.3
2024-08-15 At Loss 2024-06-13 86.3
2024-08-14 At Loss 2024-06-12 86.3
2024-08-13 At Loss 2024-06-11 86.3
2024-08-12 At Loss 2024-06-10 86.3
2024-08-09 At Loss 2024-06-07 86.3
2024-08-08 At Loss 2024-06-06 86.3
2024-08-07 At Loss 2024-06-05 86.3
2024-08-06 At Loss 2024-06-04 86.3
2024-08-05 At Loss 2024-06-03 86.3
2024-08-02 At Loss 2024-05-31 86.3
2024-08-01 At Loss 2024-05-30 86.3
2024-07-31 At Loss 2024-05-29 86.3
2024-07-30 At Loss 2024-05-28 86.3
2024-07-29 At Loss 2024-05-27 86.3
2024-07-26 At Loss 2024-05-24 86.3
2024-07-25 At Loss 2024-05-23 86.3
2024-07-24 At Loss 2024-05-22 86.3
2024-07-23 At Loss 2024-05-21 86.3

HUTCHMED (China) Ltd (MEX:HCM) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.